Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game.
| Website | http://www.eisbach.bio |
| Employees | 14 (13 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology Research, Pharmaceuticals, Biotechnology |
| Keywords | Biomarker Discovery, Cancer Drug Development, Drug Development Services, Oncology Therapeutics, Biotechnology Startup, Pharmaceutical Research, Molecular Oncology, Novel Drug Discovery, Targeted Cancer Therapy, Precision Oncology, Biopharmaceutical Research, Drug Target Identification, Genomic Medicine, Therapeutic Antibodies, Small Molecule Drugs, Immuno-Oncology, Clinical Stage Drug, Cancer Treatment |
| Competitors | Novartis, Illumina, Exact Sciences, Guardant Health, GRAIL, GeneDx, MorphoSys, Biocartis, Genomatix AG, 23andMe Inc +36 more (view full list) |
Looking for a particular Eisbach Bio GmbH employee's phone or email?
Adrian Schomburg is the CEO, CMO and Co-Founder of Eisbach Bio GmbH.
13 people are employed at Eisbach Bio GmbH.